Font Size: a A A
Keyword [Non - small cell lung cancer]
Result: 101 - 120 | Page: 6 of 10
101. Proteomics Identification Of HER-2 Protein As The Prognostic Factor Of The Surgical Treatment To NSCLC
102. A Study On The Relation Of ERCC1 Expression And The Clinical Features, Prognosis And Cis-Platinum Adjuvant Chemotherapy In Non-Small Cell Lung Cancer Patients
103. Clinical And Laboratory Study On Risk Factors Predicting Radiation Pneumonitis
104. The Expression And Clinical Significance Of NFAT Proteins In Non-small Cell Lung Cancer Tissues
105. The Rearch Of 20(S)-Protopanaxadiol Induced Apoptosis And Inhibited P13K/AKT Pathway In NSCLC A549 Cells
106. Comparison Between Phosphorylated EGFR And EGFR Mutation In Non-small Cell Lung Cancer
107. Study Of TP53, KRAS And EGFR Mutations As Bio-Markers Of Adjuvant Cisplatin-based Chemotherapy In Non-small-cell Lung Cancer
108. Molecular Prognosis And Predictions Of Response To Adjuvant Chemotherapy In Stage Ⅰ-Ⅲ Resected Patients With Non-Small Cell Lung Cancer
109. Expressional And Mutational Analysis Of Pro-apoptotic PUMA In Non-small-cell Lung Cancer
110. Signal Transduction Mechanism For AS2O3-Induced Non-small Cell Lung Cancer Cell Apoptosis
111. X-ray Induces Non-Small Cell Lung Cancer Apoptosis By Upregulating Axin Expression
112. Involvement Of CCR7 In Metastasis Of Non-Small Cell Lung Cancer
113. 1.Prognosis Of Locally Advanced Non-small Cell Lung Cancer Treated With Radiotherapy Or Chemoradiotherapy 2.The Prognostic Value Of MicroRNAs In Small Cell Lung Cancer
114. Association Between Polymorphisms In Genes Involved In Apoptosis And Drug Metabolism And The Clinical Outcome In Advanced Non-Small-Cell Lung Cancer Patients Treated With Gefitinib
115. The Study Of 18F-FDG PET-CT In The Staging Of Non-Small Cell Lung Cancer
116. Effect Of PORT For Completely Resected Stage ⅢA-N2 Non-small Cell Lung Cancer
117. Mutational And Expressional Analyses Of The Transforming Growth Factor Beta Type Ⅱ Receptor Gene In Primary Non-small Cell Lung Cancer
118. Study On The Lentiviral-Vector-Mediated SiRNA Of Cyclophilin A (CyPA) Inhibits Non-Small Cell Lung Cancer Cell Growth In Vitro And In Vivo
119. The Correlation Between Tissue Expression And Serum Level Of VEGF,Endostatin In Patients With Non-small Cell Lung Cancer And Clinical Significance
120. Clinical Significance Of Expression Of ERCC1, Class Ⅲ β Tubulin In Resected Patients With Non-small Cell Lung Cancer & Association Between Polymorphisms Of ERCC1 And Response And Survival In Advanced Non-small Cell Lung Cancer Patients Treated With Cis
  <<First  <Prev  Next>  Last>>  Jump to